Cardiff Oncology Inc (CRDF)
2.63 x 10 2.90 x 1
Post-market by (Cboe BZX)
2.75 -0.12 (-4.18%) 04/04/25 [NASDAQ]
2.63 x 10 2.90 x 1
Post-market 2.81 +0.06 (+2.18%) 19:49 ET
for Fri, Apr 4th, 2025
Results
download Want to compare other data? Select Fields| Symbol | CRDF | TERN | CDTX | ||
| Company | Cardiff Oncology Inc | Terns Pharmaceuticals Inc | Cidara Thera | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 2.80 | 2.24 | 17.20 | ||
| High | 2.82 | 2.29 | 17.20 | ||
| Low | 2.62 | 2.08 | 16.10 | ||
| Last | 2.75 | 2.10 | 16.43 | ||
| Change | -0.12 | -0.23 | -1.39 | ||
| % Change | -4.18% | -9.87% | -7.80% | ||
| Volume | 1,607,100 | 1,442,400 | 119,500 | ||
| 20-Day Average Volume | 1,205,870 | 1,154,770 | 161,370 | ||
| Previous Close | 2.87 | 2.33 | 17.82 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 3.57 | 3.07 | 21.38 | ||
| 20-Day Raw Stochastic | 7.22% | 1.22% | 4.10% | ||
| 20-Day Relative Strength | 34.49% | 24.78% | 35.15% | ||
| Weighted Alpha | -64.11 | -73.57 | -19.18 | ||
| Today's Opinion | 24% Sell | 100% Sell | 8% Sell | ||
| Previous Opinion | 24% Sell | 100% Sell | 24% Buy | ||
| Last Month's Opinion | 64% Buy | 100% Sell | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -16.41% since 03/28/25 | -28.08% since 03/28/25 | -26.62% since 03/28/25 | ||
| Low | 2.62 on 04/04/25 | 2.08 on 04/04/25 | 16.10 on 04/04/25 | ||
| High | 3.22 on 03/31/25 | 2.88 on 03/31/25 | 22.64 on 03/31/25 | ||
| 1-Month | |||||
| %Chg | -26.37% since 03/04/25 | -40.17% since 03/04/25 | -29.06% since 03/04/25 | ||
| Low | 2.62 on 04/04/25 | 2.08 on 04/04/25 | 16.10 on 04/04/25 | ||
| High | 4.42 on 03/12/25 | 3.72 on 03/21/25 | 24.14 on 03/10/25 | ||
| 3-Month | |||||
| %Chg | -41.49% since 01/03/25 | -63.48% since 01/03/25 | -38.28% since 01/03/25 | ||
| Low | 2.62 on 04/04/25 | 2.08 on 04/04/25 | 16.10 on 04/04/25 | ||
| High | 4.99 on 02/21/25 | 5.95 on 01/06/25 | 27.70 on 01/07/25 | ||
| 6-Month | |||||
| %Chg | +5.77% since 10/04/24 | -74.61% since 10/04/24 | +50.73% since 10/04/24 | ||
| Low | 2.26 on 12/06/24 | 2.08 on 04/04/25 | 10.14 on 10/15/24 | ||
| High | 5.64 on 12/17/24 | 8.43 on 10/07/24 | 28.42 on 01/02/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 182,941 | 183,326 | 179,958 | ||
| Shares Outstanding, K | 66,524 | 87,298 | 10,953 | ||
| Annual Sales | 680,000 | 0 | 1,280,000 | ||
| Annual Net Income | -45,430,000 | -88,850,000 | -169,830,000 | ||
| Last Quarter Sales | 150,000 | 0 | 0 | ||
| Last Quarter Net Income | -11,790,000 | -21,800,000 | -15,990,000 | ||
| 60-Month Beta | 1.74 | -0.13 | 0.89 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.21 on 02/27/25 | -0.24 on 03/20/25 | -5.38 on 03/06/25 | ||
| Latest Earnings Date | 05/01/25 | 05/12/25 | 05/21/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||